HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making episode artwork

EPISODE · Apr 16, 2026 · 1H

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

from Oncology Today with Dr Neil Love

Dr Seth Wander from Massachusetts General Hospital in Boston discusses the role of biomarker assessment in the management of HR-positive metastatic breast cancer. CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Apr 16, 2026

Embed this episode

NOW PLAYING

HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Optimizing Biomarker Assessment and Related Treatment Decision-Making

0:00 1:00:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 1 hour and 0 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on April 16, 2026.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!